IFF Add to watchlist $71.53 1.06 (-1.46%) Last updated: Apr 16, 2026 04:57
52-Week Range
$71.53
$59.14 $71.53 $84.45

Fundamentals Overview

International Flavors & Fragrances Inc. is in the middle of its 52-week range with low valuation, trading relatively flat today.

Valuation low

P/B 1.29 P/S 1.68

Intrinsic value (DCF)

-95% downside vs price

Risk (Beta)

1.03 — in line vol

BullzEye Analysis

Our composite tilts Sell on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Sell — 69% confidence Risk: Moderate Volatility — Beta 1.03. Diversify and only invest what you can afford to lose.

Supporting (Buy):

Sentiment improving (3 upgrades)

Pressures (Sell):

DCF 95% downside vs price

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$18.27B
P/E (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
2.24%
52-Week Range
$59.14 - $84.45
Volume vs Avg
N/A
Beta
1.03

About

International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions. It al...
Sector: Basic Materials
Headquarters: US
Employees: 22,400
IPO Date: Dec 1974
Website: www.iff.com
Beta: 1.03 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: C. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 9, Neutral: 6, Outperform: 6, Overweight: 8, Peer Perform: 1.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $3.56; current price is $71.53. That’s a -95% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) N/A
DCF value (model) $3.56 (-95% vs price)
PEG (TTM) N/A
P/B (TTM) 1.29
P/S (TTM) 1.68
P/FCF (TTM) 71.38
Liquidity & enterprise
Current Ratio (TTM) 1.42
Quick Ratio (TTM) 0.82
Cash Ratio (TTM) 0.15
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) -3.2%
Gross margin (TTM) 34.93%
Operating margin (TTM) -2.88%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for IFF.

Analyst Sentiment at a Glance

C Sentiment Improving
Buy 9Neutral 6Outperform 6Overweight 8Peer Perform 1
3 upgrades, 0 downgrades
Price Target Consensus
Current $71.53
Median $91.00
Consensus $87.75
Low consensus $75.00
High consensus $97.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Citigroup maintain Buy Buy 2026-04-13
UBS maintain Neutral Neutral 2026-04-09
Mizuho maintain Outperform Outperform 2026-02-17
Barclays maintain Overweight Overweight 2026-02-17
Oppenheimer upgrade Perform Outperform 2026-02-13
Citigroup maintain Buy Buy 2026-02-13
Wells Fargo maintain Overweight Overweight 2026-02-13
Mizuho maintain Outperform Outperform 2026-02-12
Argus Research maintain Buy Buy 2026-01-22
Citigroup maintain Buy Buy 2026-01-21
UBS maintain Neutral Neutral 2026-01-12
Barclays maintain Overweight Overweight 2025-11-07
UBS maintain Neutral Neutral 2025-11-06
B of A Securities maintain Buy Buy 2025-10-14
Argus Research maintain Buy Buy 2025-10-07
UBS maintain Neutral Neutral 2025-10-06
Citigroup maintain Buy Buy 2025-10-06
Mizuho maintain Outperform Outperform 2025-10-03
Morgan Stanley maintain Overweight Overweight 2025-09-22
Wolfe Research upgrade Underperform Peer Perform 2025-09-08
Tigress Financial maintain Buy Buy 2025-08-26
Barclays maintain Overweight Overweight 2025-08-08
Wells Fargo maintain Overweight Overweight 2025-08-07
UBS maintain Neutral Neutral 2025-08-06
Morgan Stanley maintain Overweight Overweight 2025-05-13
Barclays upgrade Equal Weight Overweight 2025-05-08
Citigroup maintain Buy Buy 2025-05-08
Baird maintain Outperform Outperform 2025-05-08
UBS maintain Neutral Neutral 2025-05-07
Oppenheimer maintain Outperform Outperform 2025-04-22